These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 790125)

  • 21. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A multicenter study of tinnitus. Epidemiology and therapy].
    Meyer B
    Ann Otolaryngol Chir Cervicofac; 1986; 103(3):185-8. PubMed ID: 3530094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Almitrine-raubasine and cognitive impairment in the elderly: results of a 6-month controlled multicenter study.
    Poitrenaud J; Piette F; Malbezin M; Sebban C; Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S100-8. PubMed ID: 2093414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental approach of treatment of cerebral ischemia by a combination of raubasine and almitrine.
    Borzeix MG; Cahn J
    Arzneimittelforschung; 1987 May; 37(5):491-4. PubMed ID: 2887170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic component of internal carotid artery stenosis in patients with cerebrovascular disease: effects of nifedipine.
    Akopov SS; Grigorian GS; Gabrielian ES
    Int J Clin Pharmacol Ther; 1994 May; 32(5):219-22. PubMed ID: 7921514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot study of the effect of raubasine on platelet biological activity.
    Neuman J; de Engel AM; Neuman MP
    Arzneimittelforschung; 1986 Sep; 36(9):1394-8. PubMed ID: 3790193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L; Hiremath ; Kerkar PG; Manade VG
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of high doses of raubasine on the rehabilitation of patients with cerebrovascular disorders].
    Fontaine C
    Sem Hop; 1968 Mar; 44(12):806-9. PubMed ID: 4300527
    [No Abstract]   [Full Text] [Related]  

  • 29. [Gycoside serum concentrations under maintenance therapy with Lanicor, Card-Lamuran, MF708d, and Lanitop (author's transl)].
    Weiss W; Olcay A; Teufel W; Glocke M
    Med Klin; 1975 Aug; 70(35):1367-74. PubMed ID: 809651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].
    Dubourg O; Guéret P; Ferrier A; Léger P; Farcot JC; Rigaud M; Beaumont D; Bardet J; Bourdarias JP
    Arch Mal Coeur Vaiss; 1983 Feb; 76(2):211-9. PubMed ID: 6407429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphetamine increases blood pressure and heart rate but has no effect on motor recovery or cerebral haemodynamics in ischaemic stroke: a randomized controlled trial (ISRCTN 36285333).
    Sprigg N; Willmot MR; Gray LJ; Sunderland A; Pomeroy V; Walker M; Bath PM
    J Hum Hypertens; 2007 Aug; 21(8):616-24. PubMed ID: 17443208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stroke and functional rehabilitation: the Chinese experience.
    Li SW
    Eur Neurol; 1998; 39 Suppl 1():26-30. PubMed ID: 9516072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the EEG effects of the combination of almitrine and raubasine in animals and humans.
    Sebban C; Tesolin B; Schatz C; Malbezin M; Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S50-8. PubMed ID: 2093418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of cerebrovascular processes and their reactions to pharmacotherapy by means of ultrasonic methods.
    Klein K; Klein M; Klein P
    Z Alternsforsch; 1985; 40(6):369-74. PubMed ID: 2934900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of the effects of almitrine, raubasine and 5023 SE on arterial oxygen desaturation during exercise].
    Sebban C; Berthaux P
    Presse Med; 1983 Mar; 12(13):847-8. PubMed ID: 6220334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological features of an almitrine-raubasine combination. Activity at cerebral levels.
    Benzi G
    Eur Neurol; 1998; 39 Suppl 1():31-8. PubMed ID: 9516073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical efficacy of almitrine-raubasine. An overview.
    Allain H; Bentué-Ferrer D
    Eur Neurol; 1998; 39 Suppl 1():39-44. PubMed ID: 9516074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cerebrovascular insufficiency in the aged: therapeutic action of piribedil. Controlled clinical study].
    De Nicola P
    Minerva Med; 1976 May; 67(26):1736-9. PubMed ID: 778672
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative effects of almitrine and raubasine, singly and in combination, on electroencephalographic activity in young and old rats.
    Sebban C; Tesolin B; Coulomb B; Berthaux P
    Exp Gerontol; 1989; 24(1):11-24. PubMed ID: 2707311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.